Deferred Federal Income Tax Expense (Benefit) of VitaNova Life Sciences Corp from 30 Apr 2023 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
VitaNova Life Sciences Corp quarterly and annual Deferred Federal Income Tax Expense (Benefit) in USD history and change rate from 30 Apr 2023 to 31 Jul 2025.
  • VitaNova Life Sciences Corp Deferred Federal Income Tax Expense (Benefit) for the quarter ending 31 Jul 2025 was $0.
  • VitaNova Life Sciences Corp annual Deferred Federal Income Tax Expense (Benefit) for 2024 was $0.
  • VitaNova Life Sciences Corp annual Deferred Federal Income Tax Expense (Benefit) for 2023 was $0.
Source SEC data
View on sec.gov
Deferred Federal Income Tax Expense (Benefit), Quarterly (USD)
Deferred Federal Income Tax Expense (Benefit), Annual (USD)

VitaNova Life Sciences Corp Quarterly Deferred Federal Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $0 $0 01 May 2025 31 Jul 2025 10-Q 12 Sep 2025 2026 Q1
Q2 2024 $0 $0 01 May 2024 31 Jul 2024 10-Q 12 Sep 2025 2026 Q1
Q2 2023 $0 01 May 2023 31 Jul 2023 10-Q 10 Sep 2024 2025 Q1

VitaNova Life Sciences Corp Annual Deferred Federal Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $0 $0 01 May 2024 30 Apr 2025 10-K 24 Jul 2025 2025 FY
2023 $0 $0 01 May 2023 30 Apr 2024 10-K 24 Jul 2025 2025 FY
2022 $0 01 May 2022 30 Apr 2023 10-K 29 Jul 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.